Feedback / Questions
MK-6105 - Merck (MSD), CSL Behring
ASLAN003 - Almirall, ASLAN
varlitinib (ASLAN001) - ASLAN
http://globenewswire.com/news-release/2019/01/29/1707283/0/en/ASLAN-Pharmaceuticals-Announces-Strategic-Prioritisation-of-Clinical-Development-Programs-and-Corporate-Restructuring.html
Jan 29, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next